Stock Evaluator: Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Shuttle Pharmaceuticals Holdings, Inc. SHPH

$3.80 0.71 22.98%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 3,047,304
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Commentary & Analysis


Financial Summary

Share Statistics SHPH Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $2.2 $252.6 1%
Shares Out (Mil) 0.5 52.3 3%
Institutional Ownership 88.7% 92.1% 57%
Float (Mil) 0.6 40.2 1%
Beta 1.22 0.95 71%
Avg Daily Volume (000s) 862 455 68%
Price Change
(52-week)
(89.8%) 52.9% 4%
Growth SHPH Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.6% na
Net Income (5yr) (71.0%) (9.9%) 4%
EPS (5yr) na 16.0% na
Dividends (5yr) na 0.0% na
Cash Flow (5yr) na (15.6%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates na na na
Current EPS na na na
Month Ago EPS na na na
# Rev Up na na na
# Rev Down na na na
Three Months Ago EPS na na na
Year/Year Chg na na na
Financials SHPH Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $38 na
Net Income (TTM) (Mil) ($11) ($43) 29%
EPS (TTM) ($38.711) ($1.600) 2%
Operating Cash Flow (TTM) (Mil) ($9) ($31) 20%
Net Cash Flow (TTM) (Mil) na $5 na
Long-Term Debt (Q1) (Mil) $0 $5 10%
Enterprise Value (Q1) (Mil) $1 $180 4%
Valuation SHPH Industry
Median
Percentile
(All Stocks)
P/B 0.63 2.56 12%
P/E na 19.0 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 0.9 na
Ratios SHPH Industry
Median
Percentile
(All Stocks)
Gross Margin na 63.8% na
Net Margin na (67.3%) na
ROA (126.4%) (49.8%) 4%
ROE (326.4%) (55.5%) 2%
Liabilities to Assets 71.7% 30.3% 67%
F-Score 3 3 na

Shuttle Pharmaceuticals Holdings, Inc. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors